These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 9247204)

  • 1. The validity of melatonin as an oncostatic agent.
    Panzer A; Viljoen M
    J Pineal Res; 1997 May; 22(4):184-202. PubMed ID: 9247204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic actions of melatonin in cancer: possible mechanisms.
    Srinivasan V; Spence DW; Pandi-Perumal SR; Trakht I; Cardinali DP
    Integr Cancer Ther; 2008 Sep; 7(3):189-203. PubMed ID: 18815150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melatonin as a chronobiotic/anticancer agent: cellular, biochemical, and molecular mechanisms of action and their implications for circadian-based cancer therapy.
    Blask DE; Sauer LA; Dauchy RT
    Curr Top Med Chem; 2002 Feb; 2(2):113-32. PubMed ID: 11899096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basic mechanisms involved in the anti-cancer effects of melatonin.
    Mediavilla MD; Sanchez-Barcelo EJ; Tan DX; Manchester L; Reiter RJ
    Curr Med Chem; 2010; 17(36):4462-81. PubMed ID: 21062257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen-signaling pathway: a link between breast cancer and melatonin oncostatic actions.
    Cos S; González A; Martínez-Campa C; Mediavilla MD; Alonso-González C; Sánchez-Barceló EJ
    Cancer Detect Prev; 2006; 30(2):118-28. PubMed ID: 16647824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melatonin's Antineoplastic Potential Against Glioblastoma.
    Moretti E; Favero G; Rodella LF; Rezzani R
    Cells; 2020 Mar; 9(3):. PubMed ID: 32138190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ELF magnetic fields, breast cancer, and melatonin: 60 Hz fields block melatonin's oncostatic action on ER+ breast cancer cell proliferation.
    Liburdy RP; Sloma TR; Sokolic R; Yaswen P
    J Pineal Res; 1993 Mar; 14(2):89-97. PubMed ID: 8320637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melatonin in cancer management: progress and promise.
    Jung B; Ahmad N
    Cancer Res; 2006 Oct; 66(20):9789-93. PubMed ID: 17047036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and Metastasis.
    Reiter RJ; Rosales-Corral SA; Tan DX; Acuna-Castroviejo D; Qin L; Yang SF; Xu K
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28420185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncostatic action of melatonin: facts and question marks.
    Pawlikowski M; Winczyk K; Karasek M
    Neuro Endocrinol Lett; 2002 Apr; 23 Suppl 1():24-9. PubMed ID: 12019348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melatonin and mammary cancer: a short review.
    Sánchez-Barceló EJ; Cos S; Fernández R; Mediavilla MD
    Endocr Relat Cancer; 2003 Jun; 10(2):153-9. PubMed ID: 12790777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melatonin's growth-inhibitory effect on hepatoma AH 130 in the rat.
    Cini G; Coronnello M; Mini E; Neri B
    Cancer Lett; 1998 Mar; 125(1-2):51-9. PubMed ID: 9566696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncostatic activities of melatonin: Roles in cell cycle, apoptosis, and autophagy.
    Targhazeh N; Reiter RJ; Rahimi M; Qujeq D; Yousefi T; Shahavi MH; Mir SM
    Biochimie; 2022 Nov; 202():34-48. PubMed ID: 35752221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melatonin: from basic research to cancer treatment clinics.
    Vijayalaxmi ; Thomas CR; Reiter RJ; Herman TS
    J Clin Oncol; 2002 May; 20(10):2575-601. PubMed ID: 12011138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect and mechanism of melatonin's action on the proliferation of human umbilical vein endothelial cells.
    Cui P; Luo Z; Zhang H; Su Y; Li A; Li H; Zhang J; Yang Z; Xiu R
    J Pineal Res; 2006 Nov; 41(4):358-62. PubMed ID: 17014693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Review on Melatonin's Effects in Cancer: Potential Mechanisms.
    Hanikoglu A; Kucuksayan E; Akduman RC; Ozben T
    Anticancer Agents Med Chem; 2018; 18(7):985-992. PubMed ID: 29173185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melatonin and cisplatin co-treatment against cancer: A mechanistic review of their synergistic effects and melatonin's protective actions.
    Rafiyan M; Davoodvandi A; Reiter RJ; Mansournia MA; Rasooli Manesh SM; Arabshahi V; Asemi Z
    Pathol Res Pract; 2024 Jan; 253():155031. PubMed ID: 38103362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does the use of melatonin overcome drug resistance in cancer chemotherapy?
    Asghari MH; Ghobadi E; Moloudizargari M; Fallah M; Abdollahi M
    Life Sci; 2018 Mar; 196():143-155. PubMed ID: 29374563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential utility of melatonin in the treatment of childhood cancer.
    Chao YH; Wu KH; Yeh CM; Su SC; Reiter RJ; Yang SF
    J Cell Physiol; 2019 Nov; 234(11):19158-19166. PubMed ID: 30945299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melatonin uses in oncology: breast cancer prevention and reduction of the side effects of chemotherapy and radiation.
    Sanchez-Barcelo EJ; Mediavilla MD; Alonso-Gonzalez C; Reiter RJ
    Expert Opin Investig Drugs; 2012 Jun; 21(6):819-31. PubMed ID: 22500582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.